Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takayuki Sumiyoshi

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Cancer Medicine|February 27, 2025
A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinomaTomohiro Fukui, Kosuke Okasho, Yukiko Okuno, et al.
International Journal of Clinical Oncology|June 17, 2024
Clinical factors predicting the outcome of salvage radiotherapy for patients with biochemical recurrence after radical prostatectomyTakeru Fujimoto, Takayuki Goto, Rihito Aizawa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 6, 2014
[Risk factors for recurrence in pT3aN0M0 renal cell carcinoma according to 2009 TNM classification]Noriaki Utsunomiya, Yuka Kono, Keiyu Matsumoto, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 2015
[THE IMPACT OF LOWER URINARY TRACT SYMPTOMS ON GENERIC HEALTH-RELATED QUALITY OF LIFE IN MALE PATIENTS WITHOUT CO-MORBIDITY]Takuya Okada, Yuka Kono, Keiyu Matsumoto, et al.
Cancer Medicine|February 22, 2023
Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapyYu Miyazaki, Takayuki Goto, Xin Li, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 1, 2025
[A Case of Pheochromocytoma Requiring Positioning and Approach Adjustments Due to Neurofibromatosis Type 1]Masakatsu Hirano, Jin Kono, Daisuke Takahashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 6, 2026
Long-Term Oncologic Outcomes After Laparoscopic Radical Nephroureterectomy: A Contemporary Analysis From a Japanese Multicenter CohortToru Kanno, Ryoichi Saito, Yuki Kita, et al.
Scientific Reports|March 13, 2019
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancerTakayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, et al.
The Prostate|May 7, 2026
Establishment and Characterization of Patient-Derived Xenograft Organoids for Personalized Treatment of Castration-Resistant Prostate CancerTakuro Sunada, Yuki Kamiyama, Maki Fujiwara, et al.
International Journal of Clinical Oncology|January 16, 2026
<sup>18</sup>F-PSMA-PET/CT in comparison with whole-body MRI and combination of conventional CT and bone scintigraphy for detection of recurrent disease in prostate cancer patients with rising PSA levels after initial definitive treatmentShiori Murata, Yusaku Moribata, Shusuke Akamatsu, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Cancer Medicine|February 27, 2025
A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinomaTomohiro Fukui, Kosuke Okasho, Yukiko Okuno, et al.
International Journal of Clinical Oncology|June 17, 2024
Clinical factors predicting the outcome of salvage radiotherapy for patients with biochemical recurrence after radical prostatectomyTakeru Fujimoto, Takayuki Goto, Rihito Aizawa, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 6, 2014
[Risk factors for recurrence in pT3aN0M0 renal cell carcinoma according to 2009 TNM classification]Noriaki Utsunomiya, Yuka Kono, Keiyu Matsumoto, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 2015
[THE IMPACT OF LOWER URINARY TRACT SYMPTOMS ON GENERIC HEALTH-RELATED QUALITY OF LIFE IN MALE PATIENTS WITHOUT CO-MORBIDITY]Takuya Okada, Yuka Kono, Keiyu Matsumoto, et al.
Cancer Medicine|February 22, 2023
Up-regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapyYu Miyazaki, Takayuki Goto, Xin Li, et al.
Hinyokika Kiyo. Acta Urologica Japonica|September 1, 2025
[A Case of Pheochromocytoma Requiring Positioning and Approach Adjustments Due to Neurofibromatosis Type 1]Masakatsu Hirano, Jin Kono, Daisuke Takahashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 6, 2026
Long-Term Oncologic Outcomes After Laparoscopic Radical Nephroureterectomy: A Contemporary Analysis From a Japanese Multicenter CohortToru Kanno, Ryoichi Saito, Yuki Kita, et al.
Scientific Reports|March 13, 2019
Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancerTakayuki Sumiyoshi, Kei Mizuno, Toshinari Yamasaki, et al.
The Prostate|May 7, 2026
Establishment and Characterization of Patient-Derived Xenograft Organoids for Personalized Treatment of Castration-Resistant Prostate CancerTakuro Sunada, Yuki Kamiyama, Maki Fujiwara, et al.
International Journal of Clinical Oncology|January 16, 2026
<sup>18</sup>F-PSMA-PET/CT in comparison with whole-body MRI and combination of conventional CT and bone scintigraphy for detection of recurrent disease in prostate cancer patients with rising PSA levels after initial definitive treatmentShiori Murata, Yusaku Moribata, Shusuke Akamatsu, et al.
Pageof 8